A Healthy Environment for a Healthy You

Bringing Healthcare Up to Speed: The Good and Bad of IT

Strategic Financing and Business Development in an Active Healthcare Industry

Consumer Driven Healthcare: Knowing What You Paid For

Sizing Healthcare to Access Underserved Markets

Healthcare Marketing in the Era of Globalization


Strategic Financing and Business Development in an Active Healthcare Industry

This panel will uncover changing tendencies in financing new biotech start-ups and biomedical innovations.  In particular, new trends in business development deals within the industry will be examined.  Panelists will be asked the following questions:  How has financing in healthcare changed in the past ten years?  How has this impacted innovation?  Are biomedical drug and device companies filling their pipelines through M&A or internal R&D?  What are the pros & cons to each approach?

Harry Kraemer '79, Clinical Professor of Management and Strategy, Kellogg School of Management

Maneesh Kumar Arora, '06, Senior Vice President and Chief Financial Officer,
Third Wave Technologies
Peter McNerney, Partner, McNerney & Partners
Scott Minick, '81, Managing Director, ARCH Venture Partners

Maneesh Kumar Arora, '06, Senior Vice President and Chief Financial Officer, Third Wave Technologies

Maneesh K. Arora (39) was most recently senior vice president and chief financial officer of Third Wave Technologies, a publicly traded molecular diagnostic company.  He successfully led the company through a sale to Hologic, a global leader in women’s healthcare for $580 million in July 2008.  Mr. Arora joined Third Wave in January 2003 with a strong background in finance and business strategy and was promoted successively to Vice President and Senior Vice President in 2004. He was appointed Chief Financial Officer in January 2006. Prior to joining Third Wave, Mr. Arora was Director of Corporate Strategy for Nalco Chemical Company. Mr. Arora began his career at Kraft Foods as a financial analyst and held several positions of increasing responsibility during his nine years there. He earned a bachelor’s degree in economics from the University of Chicago and an M.B.A from the Kellogg Graduate School of Management.

Harry Kraemer, '79, Clinical Professor of Management and Strategy, Kellogg School of Management

Harry M. Jansen Kraemer, Jr. is an executive partner with Madison Dearborn, a private equity firm based in Chicago, Illinois and a Clinical Professor of Management and Strategy at Northwestern University’s Kellogg School of Management. He was recently named the 2008 Kellogg School Professor of the Year.
 Mr. Kraemer is the former chairman and chief executive officer of Baxter International Inc. He joined Baxter in 1982 as director of corporate development.  His twenty three year career at Baxter included senior positions in both domestic and international operations. He became Baxter's chief executive officer in January 1999, and assumed the additional responsibility of chairman of Baxter's board of directors in January 2000.  Before joining Baxter, Mr. Kraemer worked for Bank of America in corporate banking and for Northwest Industries in planning and business development.
Mr. Kraemer is active in business, education and civic affairs.  He serves on the board of directors of Science Applications International Corporation, Sirona Dental Systems GmbH and VWR International, Inc. and on the board of trustees of Lawrence University, Northwestern University, The Conference Board and Evanston Northwestern Healthcare. 
Mr. Kraemer received a bachelor’s degree in mathematics and economics from Lawrence University of Wisconsin in 1977 and an MBA degree in finance and accounting from Kellogg School of Management in 1979.

Peter McNerney, Partner, McNerney & Partners

Pete has over 30 years of health care operating and venture capital experience. In addition to co-founding Thomas, McNerney & Partners, Pete co-founded Coral Ventures in 1992 where he was responsible for health care investing. Pete is currently a board member of ArKal Medical, Inc., AxioMed Spine Corporation, CNS Therapeutics, Inc., Intuity Medical, Inc., M2 Group Holdings, Inc., Torax Medical Inc. and Ascent Healthcare Solutions. Prior to joining Coral in 1992, Pete was a co-founder and Managing Partner of The Kensington Group, a firm specializing in providing management services to early stage companies in the health care field. In 1986, he founded and was Chief Executive Officer of Memtec North America, a company established to commercialize cross flow membrane microfiltration technology in North America. Previously, Pete spent 11 years with Baxter Healthcare Corporation, where he held various general management positions in the U.S., Europe, the Middle East and Southeast Asia. He has served as President of the Minnesota Venture Capital Association and currently serves on the Board of Trustees of Blue Cross and Blue Shield of Minnesota. A Certified Public Accountant, Pete received a B.A. from Yale and an M.B.A. from Stanford University.

Scott Minick, '81, Managing Director, ARCH Venture Partners

Scott Minick is a Managing Director with ARCH, joining the firm as a Venture Partner in 1998.

Mr. Minick has been instrumental in the startup, development and financing of numerous portfolio companies and serves as a board director for Achaogen, Limerick BioPharma, Celula, BIND Biosciences, Chiasma, and Sorbent Therapeutics.

From 1995 until 1998, Mr. Minick was director, President and COO of SEQUUS Pharmaceuticals, a public biopharmaceutical company that was acquired by Johnson & Johnson. From 1994 to 1995, he served as a director, President and CEO of OncoTherapeutics, a private biotechnology company. Prior to that, Mr. Minick co-founded and was a director, President and CEO of LXR Biotechnology from startup through its IPO. From 1981 to 1993, he was an executive of Baxter Healthcare, holding leadership positions in the device, service and diagnostics businesses.

He received his postgraduate training in neurobiology at the Salk Institute, an M.B.A. from Northwestern University and a B.A. with Honors from the University of California at San Diego.